Lorlatinib

ATC L01ED05

articles: 2
regulatory signals: 0
cases: 0

Articles on lorlatinib

Review 05.11.2026

Targeted therapy for metastatic NSCLC: sunvozertinib superiority and sustained lorlatinib efficacy

The review emphasizes comprehensive molecular profiling in metastatic NSCLC. Pralsetinib's benefits should be considered alongside the safety concerns noted in the source.

#lorlatinib #sunvozertinib #amivantamab #lazertinib #pralsetinib d8miq7k9f04rm.cloudfront.net

Review 05.11.2026

Selpercatinib and other perioperative strategies in localized non-small cell lung cancer

The review emphasizes molecular profiling to guide perioperative strategies in non-small cell lung cancer and highlights the potential of neoadjuvant approaches in selected patients.

#erlotinib #selpercatinib #lorlatinib #nivolumab #osimertinib d8miq7k9f04rm.cloudfront.net

Interactions mentioned in the articles

Digest for physicians

Subscribe to be among the first to get the digest when we launch it.